Clinical Trial Update: Proper Extent of Maze Intercaval Lesion

View source ↗

Summary

A Baylor Research Institute clinical trial evaluating the proper extent of Maze intercaval lesion for atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Baylor Research Institute | Conditions: Atrial Fibrillation | Status: WITHDRAWN